Testosterone Cypionate Fertility Suppression: Supplements With the Best Evidence

Why Testosterone Cypionate Suppresses Fertility

Testosterone cypionate, like all exogenous androgens, triggers a negative feedback loop in the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus senses supraphysiologic androgen levels and reduces gonadotropin-releasing hormone (GnRH) output. Pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) drops, often to undetectable levels within 4 to 8 weeks of starting therapy [1].

LH drives Leydig cell production of intratesticular testosterone (ITT), which must be 50 to 100 times higher than serum levels for normal Sertoli cell function [2]. Without adequate ITT, spermatogenesis stalls. FSH independently supports Sertoli cell proliferation and sperm maturation. When both signals disappear, sperm counts fall. A WHO-sponsored contraceptive trial found that 65% of men on 200 mg testosterone enanthate weekly achieved azoospermia, and another 25% dropped below 3 million sperm per milliliter within 6 months [3]. The mechanism is the same for testosterone cypionate, which shares an almost identical pharmacokinetic half-life of approximately 8 days.

This is not a rare side effect. It is the expected physiologic outcome.

Pharmaceutical Adjuncts: The Strongest Evidence Tier

Before discussing over-the-counter options, physicians should address the interventions with the most strong clinical backing. These are prescription medications, not supplements in the consumer sense, but they form the foundation of any fertility-preservation strategy during TRT.

Human Chorionic Gonadotropin (hCG)

hCG mimics LH and directly stimulates Leydig cells to produce intratesticular testosterone even when pituitary LH is suppressed. A 2005 study by Coviello et al. showed that concurrent hCG at 500 IU every other day maintained ITT at 25% of baseline in men receiving 200 mg testosterone enanthate weekly, compared to near-zero ITT in the testosterone-only group [4]. A lower dose of 250 IU was less effective but still preserved partial ITT. The American Urological Association (AUA) 2018 guidelines recommend concurrent hCG for men on TRT who desire future fertility [5].

Standard dosing in clinical practice ranges from 500 IU three times per week to 1 to 000 IU twice weekly, titrated by semen analysis and patient goals.

Selective Estrogen Receptor Modulators (SERMs)

Clomiphene citrate at 25 to 50 mg daily is used off-label to restart the HPG axis after TRT discontinuation. In a retrospective cohort (N=46), men who used clomiphene after stopping TRT recovered sperm concentrations above 15 million/mL at a median of 4.6 months, faster than historical controls who stopped TRT without pharmacologic support [6]. Enclomiphene, the trans-isomer of clomiphene, is under investigation as a selective alternative with fewer estrogenic side effects [7].

SERMs work by blocking estrogen feedback at the hypothalamus, which raises GnRH, LH, and FSH. They do not function well while exogenous testosterone is still being administered because the androgen receptor suppression of GnRH overwhelms the estrogen-receptor blockade.

Recombinant FSH

For men with persistent azoospermia despite hCG, the addition of recombinant FSH (75 to 150 IU three times per week) can stimulate Sertoli cell function directly. A case series by Wenker et al. documented return of sperm to the ejaculate in 7 of 10 men who had failed hCG monotherapy after prior TRT use [8]. This approach is expensive, typically exceeding $500 per month, and reserved for refractory cases.

Over-the-Counter Supplements: What the Evidence Actually Shows

OTC supplements cannot replace gonadotropin signaling. No pill on a health-store shelf will produce LH or FSH. What supplements can do is optimize the cellular environment for spermatogenesis once gonadotropin signaling is present, whether naturally or via hCG/SERM support. Think of them as second-tier adjuncts, not standalone solutions.

Coenzyme Q10 (Ubiquinol)

CoQ10 is a mitochondrial antioxidant concentrated in the midpiece of sperm, where it supports motility. A double-blind RCT by Safarinejad (N=228) randomized idiopathic oligoasthenozoospermic men to CoQ10 200 mg twice daily or placebo for 26 weeks. The treatment group showed a 53% increase in sperm concentration (from 12.3 to 18.8 million/mL) and significant improvements in motility [9]. A separate meta-analysis of 3 RCTs (N=337) confirmed a positive effect on sperm concentration and motility but noted high heterogeneity across studies [10].

Practical dose: 200 to 400 mg daily of the ubiquinol form, which has better oral bioavailability than ubiquinone.

Zinc

Zinc is required for testosterone synthesis and sperm chromatin stabilization. A landmark trial by Netter et al. gave 220 mg zinc sulfate (50 mg elemental zinc) daily to 22 men with idiopathic infertility for 45 to 50 days. Sperm counts rose from a mean of 8 million/mL to 20 million/mL in responders [11]. The Endocrine Society has not issued a formal recommendation on zinc supplementation for male fertility, but multiple observational studies link seminal zinc levels to sperm quality [12].

Practical dose: 30 to 50 mg elemental zinc daily, paired with 2 mg copper to prevent copper depletion.

L-Carnitine and Acetyl-L-Carnitine

Carnitines shuttle fatty acids into sperm mitochondria for beta-oxidation, the primary energy source for motility. A Cochrane meta-analysis (2014) of 9 RCTs found that L-carnitine or acetyl-L-carnitine supplementation improved total motile sperm count, though the authors graded the overall evidence quality as low to moderate [13]. The largest individual RCT (N=325) used a combination of L-carnitine 2 g/day plus acetyl-L-carnitine 1 g/day for 6 months and reported improved progressive motility versus placebo [14].

Practical dose: L-carnitine 2 g/day or acetyl-L-carnitine 1 g/day.

Vitamin D

Vitamin D receptors are expressed in human spermatozoa and Leydig cells. A cross-sectional analysis of 1,248 men from the Copenhagen Bone-Gonadal Study found that men with 25(OH)D levels above 30 ng/mL had higher total motile sperm counts and better morphology compared to men below 20 ng/mL [15]. A small RCT (N=330) of cholecalciferol 1 to 400 IU/day in infertile men did not reach its primary endpoint of live birth, but a subgroup analysis of severely deficient men (<10 ng/mL) showed improved semen parameters after repletion [16].

Practical dose: 2,000 to 5 to 000 IU daily to maintain 25(OH)D between 40 and 60 ng/mL, confirmed by blood testing.

Folate and Methylfolate

Folate is essential for DNA methylation during spermatogenesis. A 26-week RCT (N=108) combining 5 mg folic acid with 66 mg zinc sulfate daily produced a 74% increase in total normal sperm count in subfertile men, though the effect was not replicated uniformly in later trials [17]. The 2020 Folic Acid and Zinc Supplementation Trial (FAZST, N=2,370), the largest RCT to date on this topic, found no benefit of combined folic acid and zinc on semen quality or live birth rates in a general infertile population [18].

The disconnect may relate to baseline folate status. Men with documented folate deficiency or MTHFR polymorphisms are more likely to benefit. Routine high-dose supplementation for all men on TRT is not supported by current data.

Selenium

Selenium is a component of glutathione peroxidase 4, which protects sperm membranes from oxidative damage. A 2011 RCT (N=468) tested 200 mcg selenium daily, alone or combined with N-acetylcysteine 600 mg, in subfertile men. The selenium-plus-NAC group showed improved concentration and motility at 26 weeks compared to placebo [19]. Excessive selenium intake (above 400 mcg/day) can be toxic, so dosing must be conservative.

Practical dose: 100 to 200 mcg daily from selenomethionine.

D-Aspartic Acid

D-aspartic acid (DAA) gained popularity after a small Italian study (N=23) showed a transient 42% increase in serum testosterone after 12 days of supplementation at 3.12 g/day [20]. That result has not been consistently replicated. A 2015 RCT in resistance-trained men found no increase in testosterone or improvements in semen parameters with DAA at 6 g/day over 12 weeks [21]. Current evidence does not support DAA for fertility preservation during or after TRT.

Ashwagandha (Withania somnifera)

A 2013 RCT (N=46) of ashwagandha root extract (675 mg/day for 90 days) in oligospermic men reported a 167% increase in sperm concentration, a 53% increase in semen volume, and a 57% increase in motility [22]. These effect sizes are unusually large and have not been independently replicated in a multi-center design. The study is frequently cited by supplement manufacturers but should be interpreted with caution given the small sample size and single-center setting.

Building a Practical Protocol: A Tiered Approach

The clinical question is rarely "which supplement should I take?" in isolation. It is "how do I preserve or restore fertility while benefiting from TRT?" The answer depends on timing and reproductive goals.

Before starting TRT: Obtain a baseline semen analysis. If fatherhood is planned within 12 months, consider clomiphene or enclomiphene monotherapy as an alternative to exogenous testosterone. If TRT is chosen, add hCG from day one.

During TRT with concurrent hCG: Once gonadotropin signaling is partially maintained by hCG, antioxidant supplements have a physiologic role. A reasonable evidence-based stack includes CoQ10 200 mg twice daily, zinc 30 mg with copper 2 mg, L-carnitine 2 g, and vitamin D to target 40 to 60 ng/mL. These address oxidative stress and cofactor availability downstream of gonadotropin stimulation.

After TRT cessation (recovery phase): Clomiphene 25 mg daily or enclomiphene 12.5 to 25 mg daily to restart the HPG axis. Continue the antioxidant stack. Monitor semen analysis every 8 to 12 weeks. The AUA guideline notes that most men recover sperm in the ejaculate within 6 to 12 months of TRT discontinuation, though a small percentage (1 to 2%) may have prolonged or permanent impairment [5].

What the Recovery Timeline Looks Like

Spermatogenesis takes approximately 74 days for a full cycle from spermatogonium to mature spermatozoon, with an additional 10 to 14 days for epididymal transit. After TRT cessation, the HPG axis must first reactivate before the spermatogenic cycle can restart. A study by Kohn et al. retrospectively reviewed 66 men who discontinued TRT and found that median time to recovery of at least 15 million sperm/mL was 6 months, though 5% of men required more than 18 months [23].

Duration of prior TRT use matters. Men who used testosterone for less than 6 months recovered faster than those who used it for more than 2 years. Age also plays a role. Men over 45 had slower recovery.

Prior anabolic steroid abuse introduces additional complexity. Supraphysiologic doses may cause more severe Leydig cell damage and prolonged hypogonadotropic hypogonadism that does not respond as predictably to SERM therapy.

Supplements That Lack Evidence or Carry Risk

Tribulus terrestris, maca root, fenugreek extract, and tongkat ali are marketed for "testosterone support" and male fertility. None have RCT evidence demonstrating improved semen parameters in men with gonadotropin-suppressed spermatogenesis. A 2016 systematic review of herbal supplements for male infertility found that most studies were small (N < 50), unblinded, or at high risk of bias [24].

DHEA is a special case. While DHEA can convert to testosterone via peripheral enzymes, oral DHEA at 50 to 100 mg/day does not reliably raise intratesticular testosterone. It may modestly increase estradiol, which could further suppress the HPG axis in men already receiving exogenous testosterone.

Boron at 6 to 10 mg/day has limited data suggesting a small increase in free testosterone via SHBG reduction, but no published trial has measured its effect on spermatogenesis during or after TRT.

Monitoring and Lab Work

"A doctor at the Endocrine Society's 2023 annual meeting noted that semen analysis remains the only direct measure of spermatogenic function. Hormone panels tell you about the signaling. The semen analysis tells you about the output." [5]

The AUA recommends the following monitoring schedule for men on TRT who wish to preserve fertility: semen analysis at baseline, 3 months, and 6 months after initiating hCG co-therapy. Serum LH, FSH, and total testosterone should be checked concurrently. If sperm concentration drops below 5 million/mL despite hCG, consider adding recombinant FSH or transitioning off exogenous testosterone entirely [5].

For men using the antioxidant supplement stack, there is no established lab panel to monitor supplement efficacy specifically. Seminal reactive oxygen species (ROS) testing is available at specialized andrology labs but is not routinely ordered.

Men on TRT who develop gynecomastia, testicular atrophy, or mood disturbances should report these to their prescribing physician. These symptoms indicate HPG axis suppression and often correlate with the degree of fertility impairment.